Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They can PR all about spoofing and wolf packs and deadlines they never hit, but not about actual data from the trial.
You would think with 1.8 million pages, they'd have provided that data in the JAMA article.
Just like they need him to push the BS 2015 IA storyline until the cat was out of the bag.
Newsflash flipper. If the company doesn't provide data or explanations for big questions, it's because the answer sucks.
It costs a lot at Kinkos to copy 1.8 million pages (or whatever BS they made up at the time).
Linda has some yachts to pay for.
Gary is understanding it from his imagination. He always wishes and hopes and believed but never provides links.
They haven't released the "comprehensive data set". Where's the original control arm data?
And they don't have nearly enough data for the ECA. No patient level data makes it a non-starter.
The scrap heap automated processing still needs to go through equivalency testing, just as it did when they acquired it. That hasn't happened either.
They couldn't give the platform away to BP because BP doesn't want it. If they did, they'd have it by now.
Not responding is not the same as "agreeing" despite what Liau with zero clinical trial submission experience claims.
Companies that design unique trials actually communicate with the FDA and get written approval. Those companies also PR the approval.
Actual approval for the hybrid ECA for rGBM from the FDA
They actually talked to the FDA and through that communication they designed a hybrid ECA with an internal control arm AND complete patient level data for the ECA as required by the FDA.
He's free now? He used to be paid $0.12 a day to spout BS here.
It's easy to protect worthless stuff.
So that’s why you post so much. Because you are an idiot gambling on a shitty penny stock and probably down big.
Please done use the “paper loss” BS. Just hand your wife your negative NWBO holding statement and say “here’s your ring”.
Desperate for what exactly? For the company to admit that DCVax does nothing? I've known that since 2015. I just check in to see morons like you who don't even understand the basics of how drugs are approved, or how trials are designed.
Remember Spicoli 4:20 - "Dstock is an idiot."
The company is broke. Those are the "insufficient financial terms".
Share price would be higher if the results of the P3 signed an NDA.
It was hampered in the P1 because it didn't work. If the efficacy endpoint is response rate and it shows none, that kind of hampers it, don't ya think?
Because it's bullshit started by the shills of the company. They'll need to run trials for the applications for which they seek approval.
Why would Merck still be running trials on Keytruda for new designations?
The shills think any peep from the FDA regarding any change to any process for drug/biologic approval MUST BE BECAUSE OF NWBO and all their backroom deals with the FDA and BP.
What contract? That was the question. The answer should be a copy/paste and a link.
Did they say P3 trials that are a trainwreck that are changed post hoc with bullshit ECAs are great acquisition targets?
IF anyone was interested in this POS, that interest left when they completely changed the trial protocol to something non-approvable.
If it was as easy as changing endpoints to make results look good BP would've done it long ago.
NWBO is probably still paying Cognate (LP) through some back door deal. Cognate LP and Advent LP are much better negotiators than NWBO LP.
I've heard about all that since 2014. Still the same. Nothing from the company but a changed up, poorly designed mess of a trial with shitty data that they won't dare submit to the FDA. They only want 3 British people laughing at them with the MHRA rejection, not hundreds from FDA rejection.
Lemme guess, Cofer gonna get me? Maybe when he finishes his Metamucil.
You are Johnny come lately to this turd. And you'll be gone soon enough too, just like the many before you. Disappearing hype men and women. Surprised Senti lasted this long. She should cut losses like RKMatters. I guess she has too many people mired in losses to bail.
Yes and I said dstock "took him over" with regard to a connect the dot post. IF flipper was a 5 out of 10 that would imply ANY of his connect the dot, follow the breadcrumb posts came true. They haven't.
Congratulations. You have taken over from flipper as the poster who posts the most far fetched connect the dots in the history of this company.
Merck gives zero shits about a company running a 15 year 300 patient P3 that they had to completely overhaul 5 years after most of the patients were already deceased.
They had ONE. He provided enough money where they shouldn't have needed to add a billion shares to OS. They screwed him.
Where's that $25-50 billion market cap you been touting here since 2020 you moron? You essentially cut and paste the same ridiculous claims about this company and the other turds you might own. And they all suck.
Plenty of money from Woodford to complete the P3 and move Direct forward if either did anything. LP even said as much.
Where's that $100 million? (the answer is out the door with Cognate and funding Advent so they can get paid by other biotechs to financially benefit LP even if NWBO goes bankrupt).
No need to “hang around”. I open a tab in a browser since I work in IT and keep track of my real stocks while watching idiots like you make excuses for this scam.
I’ll remind you like I’ve reminded everyone else. I’ve actually made money trading this piece of crap. That makes me much more qualified to give financial advice on it than almost anyone else that posts here.
No need to “hang around”. I open a tab in a browser since I work in IT and keep track of my real stocks while watching idiots like you make excuses for this scam.
I’ll remind you like I’ve reminded everyone else. I’ve actually made money trading this piece of crap. That makes me much more qualified to give financial advice on it than almost anyone else that posts here.
TLD is ammo. It sucked. The trial was changed post hoc, and the ECA is bullshit. The fact that they didn't submit to the FDA means they have no confidence and know it would get tossed back at them and require another trial.
This board is to discuss the "investment" of NWBO. My point that it is a scammy piece of crap and nobody in their right mind should buy the stock unless they are tracking the pump and dump share price and buying and selling accordingly like I did is certainly better investment advice than all those idiots who think this has a chance to go above $2/share and should keep buying through plummeting share prices on main events like TLD, database lock, etc.
Please post your holdings screen cap, along with name, buys, etc to prove you actually hold shares. I don't think the majority of shills here own any shares. Being paid minimum wage by NWBO's 4 IR firms is a better wage than expecting to make money off of selling shares.
Moot point. There are no suitor BPs because they've seen the data and the trial.
They are being used by other companies who are paying Advent even though NWBO shareholders paid for them.
PepGen is just one example
Mesobank is another.
You know who else has big freezers? Baskin Robbins. Guess those are all for DCVax too.
Were your recommendations to "go after the wolf pack on IHUB"? One of them shoulda been "find out where the hell all the money has gone."
Did you mention to him that every crappy OTC stock board on IHUB whines about naked shorting when their stock goes from $12 to $0.62?
So they submitted to the MHRA in Jan 23 and FDA in April 23. They planned to submit to all RAs in the same timeframe, so order didn't matter.
Yet NWBO hasn't indicated if they are submitting to the FDA any time soon.
So your point is?
And DCVax still wouldn't be approved.
Sounds great. Because we all know congressman care about the stock market. They only care about being able to trade on insider info. That's why attempts to ban congressional stock trading have failed.
They certainly don't care about an OTC penny stock that trades 1.75 million shares a day but is approaching 2 billion OS or a random dude complaining about non-existent shorting of an OTC stock.
dstock needs a better source of info than Les Goldman.
Seems like all all these qualified SAB members would have helped considering how this announcement was praised and approval was right around the corner.
But that was 2016.
You don’t develop an SAP after all the participants have been treated and the outcome already known. You also don’t change endpoints after all that happened. There’s a reason they didn’t submit shit to the FDA.
You apparently can’t read FDA guidance, have never submitted a FOIA request, or successfully invested in biotech.
So take a seat, chump.
Zero for (insert large number here).
Or did you mean criminal?
Moot and irrelevant are results after changing endpoints.